Tilray Brands, Inc. (TLRY) Balance Sheet

The most alarming trend is not simply the magnitude of shrinkage but its composition: retained losses deepened by roughly $1.4 billion from -$3.6 billion to -$5.0 billion across ten quarters, while goodwill was written down by approximately $1.9 billion. This combination suggests the 2025 impairments did not mark a clean reset but rather the beginning of an ongoing erosion pattern, consistent with the prior income statement finding of operating losses re-emerging post-impairment. With equity now representing just 31% of a materially smaller asset base versus 80% a year ago, the cushion protecting creditors and shareholders has narrowed considerably.

The goodwill collapse from prior acquisitions, which once comprised nearly half of total assets, confirms that the strategic thesis underpinning TLRY's expansion has been substantially invalidated by the market. More troubling is the PPE line, which swung from $796.1 million in 2026Q2 to just $17.9 million in 2026Q3, then recovered to $722.5 million in 2026Q4 before collapsing again to $42.0 million in 2027Q1 — volatility so extreme it suggests significant asset disposals, reclassifications, or further write-downs. If this represents genuine reduction in productive capacity, the shrinking manufacturing footprint would align with the prior cash flow finding of declining depreciation and a contracting revenue base.

The current ratio compression of roughly 33% in two quarters, driven by both declining cash and stable-to-rising short-term obligations within the $721.3 million liability stack, signals that the company's working capital buffer is thinning faster than headline figures imply. At $215 million in cash against an approximate $40–48 million quarterly FCF burn rate, the implied runway appears to be roughly four to five quarters absent a reversal in cash generation. The modest total debt reduction from $527.7 million to $304.0 million provides some net-debt relief — net debt stands at roughly $89 million — but refinancing flexibility should be monitored given negative operating income trends.

The persistent deepening of the retained earnings deficit, worsening by approximately $1.4 billion across the period despite the large non-cash impairment charges already reflected in the write-downs, suggests operating losses continue to compound the equity erosion independently of one-time events. With no share repurchases and no dividends over the full ten-quarter window, the equity base has been reduced purely through operational losses and asset impairments — a pattern that eliminates any possibility of book value recovery absent a fundamental business turnaround. The low D/E ratio of 0.19 may appear conservative on its face, but it reflects a shrinking equity denominator alongside declining absolute debt, and should not be mistaken for balance sheet strength.